Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
0.6672
-0.0608 (-8.35%)
Dec 31, 2025, 4:00 PM EST - Market closed
Bluejay Diagnostics Employees
Bluejay Diagnostics had 7 employees as of December 31, 2024. The number of employees decreased by 3 or -30.00% compared to the previous year.
Employees
7
Change (1Y)
-3
Growth (1Y)
-30.00%
Revenue / Employee
n/a
Profits / Employee
-$978,666
Market Cap
1.21M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7 | -3 | -30.00% |
| Dec 31, 2023 | 10 | -6 | -37.50% |
| Dec 31, 2022 | 16 | 7 | 77.78% |
| Dec 31, 2021 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BJDX News
- 3 days ago - Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production - GlobeNewsWire
- 2 months ago - Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 3 months ago - Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 3 months ago - Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform - GlobeNewsWire
- 5 months ago - Bluejay Diagnostics Provides Second Quarter Business and Corporate Update - GlobeNewsWire
- 7 months ago - Bluejay Diagnostics Provides Mid-Year Business and Corporate Update - GlobeNewsWire
- 9 months ago - Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting - GlobeNewsWire
- 9 months ago - Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds - GlobeNewsWire